Revision of the Classical Dopamine D2 Agonist Pharmacophore Based on an Integrated Medicinal Chemistry, Homology Modelling and Computational Docking Approach

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurochemical Research

• Publication date

  2014-07-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11064-014-1314-2PMID 25056287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GPCRdb: an information system for G protein-coupled receptors

  2015cited by this paper
• Novel aza-analogous ergoline derived scaffolds as potent serotonin 5-HT₆ and dopamine D₂ receptor ligands.

  2014cited by this paper
• Structural Basis for Molecular Recognition at Serotonin Receptors

  2013cited by this paper
• Action of benzimidazolo-piperazinyl derivatives on dopamine receptors

  2013cited by this paper
• Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody

  2013cited by this paper
• Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody

  2013cited by this paper
• Novel bivalent ligands for D2/D3 dopamine receptors: Significant co-operative gain in D2 affinity and potency.

  2012cited by this paper
• The Physiology, Signaling, and Pharmacology of Dopamine Receptors

  2011cited by this paper
• Ongoing and future developments at the Universal Protein Resource

  2011cited by this paper
• Lifting the lid on GPCRs: the role of extracellular loops

  2011cited by this paper
• Inside Cover: Selective Pharmacophore Models of Dopamine D1 and D2 Full Agonists Based on Extended Pharmacophore Features (ChemMedChem 2/2010)

  2010influential reference
• Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

  2010cited by this paper
• Ongoing and future developments at the Universal Protein Resource

  2010cited by this paper
• Syntheses of aza-analogous iso-ergoline scaffolds using carbene mediated C–H insertion

  2010cited by this paper
• Selective Pharmacophore Models of Dopamine D1 and D2 Full Agonists Based on Extended Pharmacophore Features

  2010cited by this paper
• Structure of a nanobody-stabilized active state of the β2 adrenoceptor

  2010cited by this paper
• Candidate gene studies of ADHD: a meta-analytic review

  2009cited by this paper
• N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.

  2009cited by this paper
• Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore model.

  2008cited by this paper
• Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation.

  2008cited by this paper
• Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis

  2007cited by this paper
• Dopamine: 50 years in perspective.

  2007cited by this paper
• Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N‐desmethylclozapine and preclamol at dopamine D2L receptors are modified by co‐transfection of D3 receptors: potential role of heterodimer formation

  2007cited by this paper
• Clustal W and Clustal X version 2.0

  2007cited by this paper
• Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.

  2006cited by this paper
• Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.

  2006cited by this paper
• Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor.

  2002cited by this paper
• Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D 2 -Like Receptor and (cid:1) 1 / (cid:1) 2 -Adrenoceptor

  2002cited by this paper
• The PyMOL Molecular Graphics System

  2002cited by this paper
• A Paradigm Shift in Brain Research

  2001cited by this paper
• Neuronal cell death in Huntington's disease: a potential role for dopamine.

  2000cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Ergotamine in the acute treatment of migraine: a review and European consensus.

  2000cited by this paper
• Alkaloid binding and activation of D2 dopamine receptors in cell culture.

  1999cited by this paper
• New generation dopaminergic agents. 5. Heterocyclic bioisosteres that exploit the 3-OH-N1-phenylpiperazine dopaminergic template.

  1998cited by this paper
• Dopamine receptors: from structure to function.

  1998cited by this paper
• A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.

  1998cited by this paper
• [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

  1998cited by this paper
• Conformational energy penalties of protein-bound ligands

  1998cited by this paper
• Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolites.

  1997cited by this paper
• New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans.

  1997cited by this paper
• Dopamine Receptors: Studies on Structure and Function

  1996cited by this paper
• [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors

  1995cited by this paper
• Brain Biochemistry and Brain Disorders

  1993cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• Heterogeneity of dopamine receptors.

  1993cited by this paper
• Molecular biology of dopamine receptors.

  1992cited by this paper
• Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.

  1992cited by this paper
• Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

  1991cited by this paper
• Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine.

  1991cited by this paper
• Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

  1991cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model.

  1990cited by this paper
• Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilines.

  1988cited by this paper
• Synthesis and Dopaminergic Activity of trans-4-Methyl-3-phenylpyrrolidines.

  1988cited by this paper
• N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.

  1987influential reference
• Indolizidine and quinolizidine derivatives of the dopamine autoreceptor agonist 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP).

  1987cited by this paper
• A molecular mechanics approach to the understanding of presynaptic selectivity for centrally acting dopamine receptor agonists of the phenylpiperidine series.

  1986cited by this paper
• Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].

  1984cited by this paper
• The conformation of dopamine at its receptor: binding of monohydroxy-2-aminotetralin enantiomers and positional isomers.

  1979cited by this paper
• N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity.

  1979cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.

  1978cited by this paper
• CEREBRAL DOPAMINE AGONIST PROPERTIES OF SOME 2-AMINOTETRALIN DERIVATIVES AFTER PERIPHERAL AND INTRACEREBRAL ADMINISTRATION

  1977cited by this paper
• Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration.

  1977cited by this paper
• Antipsychotic drug doses and neuroleptic/dopamine receptors

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

  1976cited by this paper
• Synthesis and dopaminergic activity of (+/-)-, (+)-, and (-)-2-dipropylamino-5-hydroxy-1,2,3,4-tetrahydronaphthalene.

  1976cited by this paper
• SYNTHESIS AND PHARMACOLOGY OF SOME 2-AMINOTETRALINS, DOPAMINE RECEPTOR AGONISTS

  1975cited by this paper
• Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists.

  1975cited by this paper
• The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs.

  1970cited by this paper
• Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system.

  1960cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper
• The FASEB Journal • FJ Express Full-Length Article Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin

  year unknowncited by this paper

• Efficiency of Homology Modeling assisted Molecular Docking in G-protein coupled receptors.

  2020cites this paper
• Integration on Ligand and Structure Based Approaches in GPCRs

  2017cites this paper